Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trega Biosciences (TRGA), formerly HPIP -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (84)	1/6/2000 4:26:00 PM
From: bob zagorin	Read Replies (1) \| Respond to of 152

Dupont Becomes a Trega Biosciences Chem.Folio Customer SAN DIEGO, Jan. 6 /PRNewswire/ -- Trega Biosciences, Inc. (Nasdaq: TRGA), today announced that it has signed an agreement to supply DuPont Crop Protection, a business unit of DuPont (NYSE: DD), with non-exclusive small-molecule, combinatorial chemistry libraries through its Chem.Folio(TM) program. Under the terms of the agreement, Trega will receive an up front payment for compounds and associated information, plus potential milestones and royalties, including the possibility of further collaboration in the future. Financial terms of the agreement were not disclosed. "Trega is pleased to supply DuPont, our first agrochemical customer, with Chem.Folio compounds," said Michael G. Grey, President and CEO of Trega. "The diversity of Chem.Folio compounds as well as their associated information, which has proven to be valuable in the pharmaceutical arena, can now have beneficial applications in the agricultural sector. DuPont's purchase of Chem.Folio libraries emphasizes their broad utility and application." Elmo Beyer, Vice President for Strategic R&D Planning for DuPont's agriculture and nutrition businesses, noted that "We are indeed pleased to gain access to the creativity imbedded in the chemical diversity of Trega's library of compounds as one element of DuPont's extensive high throughput screening effort for novel crop protection products." Trega Biosciences is an information-driven company focused on accelerating the process of drug discovery from disease targets to clinical candidates by using small molecule combinatorial chemistry, high throughput screening and predictive bioinformatics to rapidly create novel drug candidates having greater chances of clinical success. In combination with its wholly owned subsidiary, NaviCyte, Trega offers integrated products and services spanning the drug discovery process - beginning with synthesizing novel compounds to providing uniquely qualified drug leads -- to the pharmaceutical and biopharmaceutical industries. Trega also uses its drug discovery technologies in its internal development programs, which are focused on discovering small molecules acting on melanocortin receptors, which may be important in the treatment of inflammatory and metabolic diseases. DuPont is a science company, delivering science-based solutions that make a difference in people's lives in food and nutrition; health care; apparel; home and construction; electronics; and transportation. Founded in 1802, the company operates in 65 countries and has 97,000 employees. Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties, including whether this collaboration will be successful, any additional collaborations or alliances will be agreed to, formed or expanded, whether regulatory approvals can be obtained for products discovered and developed, if any, the impact of competitive products and pricing, whether any other corporate collaborations or alliances will be successful, and other risks detailed from time to time in Trega's Securities and Exchange Commission filings. These forward-looking statements represent Trega's judgment as of the date of this release. Actual results may differ materially from those projected. Trega disclaims, however, any intent or obligation to update these forward-looking statements. SOURCE Trega Biosciences, Inc. CO: Trega Biosciences, Inc.; DuPont Crop Protection; DuPont ST: California IN: MTC CHM SU: LIC 01/06/2000 16:12 EST prnewswire.com